Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

SOHO 2026

The 14th Annual Meeting of the Society of Hematologic Oncology

09–12 September 2026 | Houston, TX

The 14th Annual Meeting of the Society of Hematologic Oncology (SOHO) took place on September 9-12, 2026, in Houston, TX, and online. This meeting brought world leaders together to discuss the latest advances and practical clinical applications in hematologic malignancies.

View all videos

Lessons from the US: treatment access and patient-guided treatment selection in MCL

Elise Chong • 10 Sep 2026

ESAs, luspatercept, and imetelstat: treatment selection and sequencing in LR-MDS

Valeria Santini • 11 Sep 2026

The ongoing Phase III ELRISE trial: exploring elritercept in LR-MDS treatment

Valeria Santini • 11 Sep 2026

Transplant decision-making: autoSCT vs alloSCT in T-cell lymphoma

Mary Jo Lechowicz • 11 Sep 2026

Expanding outpatient delivery of bispecific antibodies in multiple myeloma

Hans Lee • 10 Sep 2026

Emerging therapies after BCMA- and GPRC5D-directed treatment in multiple myeloma

Hans Lee • 10 Sep 2026

Referral and transplant-timing decisions in AML: advice for community physicians

Iskra Pusic • 11 Sep 2026

Incorporating patient goals into frontline TKI selection in CML

Jorge Cortes • 10 Sep 2026

Lessons from the US: treatment access and patient-guided treatment selection in MCL

Elise Chong • 10 Sep 2026

Transplant decision-making: autoSCT vs alloSCT in T-cell lymphoma

Mary Jo Lechowicz • 11 Sep 2026

The ongoing Phase III ELRISE trial: exploring elritercept in LR-MDS treatment

Valeria Santini • 11 Sep 2026

Three-year survival update of pre-induction azacitidine and venetoclax in newly diagnosed AML

Maher Salamoon • 8 Sep 2026